Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525862 · ClinicalTrials.gov registry record · NA
XprESS Maxillary Balloon Dilation Study
A NA study of Chronic Rhinosinusitis (Diagnosis) and Chronic Sinusitis, sponsored by Entellus Medical.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 2
- Study locations
NCT01525862 is a NA study of Chronic Rhinosinusitis (Diagnosis) and Chronic Sinusitis that has completed, run by Entellus Medical. The registered enrollment target is 21 participants, below the 88-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01525862, a NA study of Chronic Rhinosinusitis (Diagnosis) and Chronic Sinusitis, has completed, sponsored by Entellus Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, single-arm, post approval pilot study.
Conditions Studied
Interventions
- DEVICE Balloon sinus dilation
Study Locations (2)
Minnesota
- Entellus Medical - Plymouth
Missouri
- Synergy ENT Specialists - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01525862
The ClinicalTrials.gov registry entry for NCT01525862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 88-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (76% lower). The listed sponsor is Entellus Medical, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Rhinosinusitis (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Balloon sinus dilation is the first listed.
NCT01525862 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Missouri.
Frequently Asked Questions
What is clinical trial NCT01525862 about?
NCT01525862 is a clinical study titled "XprESS Maxillary Balloon Dilation Study". A prospective, single-arm, post approval pilot study.
What is the current status of trial NCT01525862?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-12. Estimated completion is 2013-01.
What conditions does trial NCT01525862 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis (Diagnosis), Chronic Sinusitis.
What interventions are being tested in trial NCT01525862?
The interventions under investigation include: Balloon sinus dilation (DEVICE).
Who is sponsoring clinical trial NCT01525862?
This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01525862 being conducted?
This trial has 2 study locations across Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
RECRUITING · Early Phase 1
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
RECRUITING · Phase 2
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
RECRUITING
-
The Sinonasal Microbiome
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.